Publikation

Dose and image quality of high-pitch dual source computed tomography for the evaluation of cervical lymph node status - comparison to regular 128-slice single source computed tomography

Wissenschaftlicher Artikel/Review - 14.02.2013

Bereiche
PubMed
DOI

Zitation
Bodelle B, Bauer R, Holthaus L, Schulz B, Al-Butmeh F, Wichmann J, Beeres M, Vogl T, Kerl J. Dose and image quality of high-pitch dual source computed tomography for the evaluation of cervical lymph node status - comparison to regular 128-slice single source computed tomography. Eur J Radiol 2013; 82:e281-5.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Eur J Radiol 2013; 82
Veröffentlichungsdatum
14.02.2013
eISSN (Online)
1872-7727
Seiten
e281-5
Kurzbeschreibung/Zielsetzung

PURPOSE
A high-pitch dual-source CT (DSCT) was compared to a standard single-source CT protocol in terms of dose and image quality for malignant lymphoma staging.

MATERIALS AND METHODS
Data from 43 patients who underwent DSCT (group 1) of the neck for staging of malignant lymphoma and 40 patients who underwent regular single source CT (group 2) were investigated retrospectively. Volume CT dose index (CTDIvol), dose length product (DLP), background noise (BN), attenuation values, signal-to-noise-ratio (SNR), scan time, effective tube current-time product (eff. mAs), subjective diagnostic image quality and artifact burden were compared.

RESULTS
CTDIvol (5.5 ± 0.8 mGy vs. 12.4 ± 1.4 mGy), DLP (172 ± 27 mGycm vs. 344 ± 60 mGycm, p<0.0001), eff. mAs (98 ± 15 mAs vs. 183 ± 20 mAs, p<0.0001) and scan time (0.64 ± 0.05 s vs. 8.21 ± 0.72 s) were lower for group 1. BN was higher (p<0.001) for group 1 with a mean difference of 2.6 HU. SNR for sternocleidomastoid and pectoral muscle was lower (6.6-12.3 vs. 7.8-19.1) for group 1. Subjective image quality (1.55 ± 0.6 vs. 1.42 ± 0.5) and artifact burden (1.62 ± 1.0 vs. 1.57 ± 0.9) were not rated significantly different (p=0.47 and p=0.80) with a good inter-observer agreement (κ=0.59-0.90).

CONCLUSION
High-pitch DSCT allows reduction of patient dose for cervical lymphoma staging while diagnostic image quality is preserved.